We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Electromed Inc | AMEX:ELMD | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.81 | 0 | 12:00:12 |
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in Canaccord Genuity’s 41st Annual Growth Conference, to be held virtually, on August 10-12, 2021.
Below are the details for Electromed’s group presentation:
A link to the webcast also will be available in the Investor Relations section of Electromed’s website at: http://investors.smartvest.com/investor-relations-home/default.aspx.
About Electromed, Inc.
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210802005034/en/
Electromed, Inc. Kathleen Skarvan, President and Chief Executive Officer (952) 758-9299 investorrelations@electromed.com
The Equity Group Inc. Kalle Ahl, CFA (212) 836-9614 kahl@equityny.com
Devin Sullivan (212) 836-9608 dsullivan@equityny.com
1 Year Electromed Chart |
1 Month Electromed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions